Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1958 1
1961 5
1962 3
1963 1
1965 3
1966 5
1967 3
1968 12
1969 8
1970 7
1971 11
1972 7
1973 7
1974 9
1975 5
1976 14
1977 9
1978 9
1979 22
1980 16
1981 14
1982 25
1983 24
1984 27
1985 35
1986 25
1987 37
1988 35
1989 41
1990 41
1991 38
1992 64
1993 65
1994 56
1995 55
1996 61
1997 46
1998 56
1999 55
2000 81
2001 74
2002 64
2003 81
2004 74
2005 64
2006 96
2007 96
2008 119
2009 125
2010 101
2011 125
2012 147
2013 131
2014 103
2015 110
2016 143
2017 134
2018 155
2019 188
2020 218
2021 214
2022 213
2023 180
2024 84

Text availability

Article attribute

Article type

Publication date

Search Results

3,701 results

Results by year

Filters applied: . Clear all
Page 1
Structure Transformation of Methylammonium Polyoxomolybdates via In-Solution Acidification and Solid-State Heating from Methylammonium Monomolybdate and Application as Negative Staining Reagents for Coronavirus Observation.
Sukmana NC, Sugiarto, Shinogi J, Minato T, Kojima T, Fujibayashi M, Nishihara S, Inoue K, Cao Y, Zhu T, Ubukata H, Higashiura A, Yamamoto A, Tassel C, Kageyama H, Sakaguchi T, Sadakane M. Sukmana NC, et al. Among authors: kojima t. Inorg Chem. 2024 May 20. doi: 10.1021/acs.inorgchem.4c00543. Online ahead of print. Inorg Chem. 2024. PMID: 38767574
Comparison of Cabozantinib and Axitinib as Second-line Therapy After Nivolumab Plus Ipilimumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Comparative Analysis of Retrospective Real-world Data.
Tomida R, Takahashi M, Matsushita Y, Kojima T, Yamana K, Kandori S, Bando Y, Nishiyama N, Yamashita S, Taniguchi H, Monji K, Ishiyama R, Tatarano S, Masui K, Matsuda A, Kaneko T, Motoshima T, Shiraishi Y, Kira S, Murashima T, Hara H, Matsumura M, Kitamura H, Miyake H, Furukawa J; Japanese Urological Oncology Group. Tomida R, et al. Among authors: kojima t. Clin Genitourin Cancer. 2024 Apr 15:102094. doi: 10.1016/j.clgc.2024.102094. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 38714434
Risk factors for decreased bone mineral density in patients with metabolic dysfunction-associated steatotic liver disease: A cross-sectional study at a health examination center.
Yokoyama S, Honda T, Ishizu Y, Imai N, Ito T, Yamamoto K, Mizuno K, Kojima T, Kariya N, Nakamura M, Kawashima H. Yokoyama S, et al. Among authors: kojima t. Clin Nutr. 2024 Apr 29;43(6):1425-1432. doi: 10.1016/j.clnu.2024.04.034. Online ahead of print. Clin Nutr. 2024. PMID: 38703510 Free article.
A preliminary survey of rheumatologists on the management of late-onset rheumatoid arthritis in Japan.
Takanashi S, Kaneko Y, Kawahito Y, Kida T, Sugihara T, Kojima T, Harada R, Ishitoku M, Hirata S, Hashimoto M, Hidaka T, Abe A, Ishikawa H, Ito H, Kishimoto M, Matsui K, Matsui T, Matsushita I, Onishi A, Morinobu A, Nishida K, Asai S, Tanaka E, Harigai M, Kojima M. Takanashi S, et al. Among authors: kojima t. Intern Med. 2024 May 2. doi: 10.2169/internalmedicine.3288-23. Online ahead of print. Intern Med. 2024. PMID: 38692915 Free article.
3,701 results